JOHN B. HENNEMAN III - 18 Jun 2025 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role: Director
Signature: /s/ J. Andres Cedron, attorney-in-fact
Issuer symbol: OFIX
Transactions as of: 18 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 23 Jun 2025, 16:15:44 UTC
Previous filing: 09 Jun 2025
Next filing: 24 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
HENNEMAN JOHN B III	Director	3451 PLANO PARKWAY, LEWISVILLE	/s/ J. Andres Cedron, attorney-in-fact	23 Jun 2025	0001187572

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OFIX	Common Stock	Award	$0	+18,841	+29%	$0.000000	83,706	18 Jun 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
F2	Includes 29,506 previously reported deferred stock units and 951 shares acquired under Orthofix's Stock Purchase Plan on 4/30/2025.

Content

Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

Includes 29,506 previously reported deferred stock units and 951 shares acquired under Orthofix's Stock Purchase Plan on 4/30/2025.